Can serum albumin level affect the pharmacological action of tolvaptan in patients with liver cirrhosis? A post hoc analysis of previous clinical trials in Japan-Reference-Cited by-同舟云学术

Can serum albumin level affect the pharmacological action of tolvaptan in patients with liver cirrhosis? A post hoc analysis of previous clinical trials in Japan

Published:2015-02-18 Issue:10 Volume:50 Page:1047-1053
ISSN:0944-1174
Container-title:Journal of Gastroenterology
language:en
Short-container-title:J Gastroenterol

Author:

Sakaida Isao,Nakajima Koji,Okita Kiwamu,Hori Masatsugu,Izumi Tohru,Sakurai Masaya,Shibasaki Yoshiyuki,Tachikawa Sayaka,Tsubouchi Hidetsugu,Oka Hiromi,Kobayashi Hiroyuki

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology

Link

http://link.springer.com/content/pdf/10.1007/s00535-015-1052-5.pdf

Reference31 articles.

1. Biecker E. Diagnosis and therapy of ascites in liver cirrhosis. World J Gastroenterol. 2011;17:1237–48.

2. Hasselblad V, Gattis Stough W, Shah MR, et al. Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial. Eur J Heart Fail. 2007;9:1064–9.

3. Costanzo MR, Jessup M. Treatment of congestion in heart failure with diuretics and extracorporeal therapies: effects on symptoms, renal function, and prognosis. Heart Fail Rev. 2012;17:313–24.

4. Madan K, Mehta A. Management of renal failure and ascites in patients with cirrhosis. Int J Hepatol. 2011. doi: 10.4061/2011/790232 .

5. Kitsios GD, Mascari P, Ettunsi R, et al. Co-administration of furosemide with albumin for overcoming diuretic resistance in patients with hypoalbuminemia: a meta-analysis. J Crit Care. 2014;29:253–9.

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tolvaptan reduces the required amount of albumin infusion in patients with decompensated cirrhosis with uncontrolled ascites : a multicenter retrospective propensity score-matched cohort study;Acta Gastro Enterologica Belgica;2021-02-16

2. Tolvaptan therapy of Chinese cirrhotic patients with ascites after insufficient diuretic routine medication responses: a phase III clinical trial;BMC Gastroenterology;2020-11-19

3. Impact of acute kidney injury on prognosis and the effect of tolvaptan in patients with hepatic ascites;Journal of Gastroenterology;2020-09-21

4. Management of refractory ascites attenuates muscle mass reduction and improves survival in patients with decompensated cirrhosis;Journal of Gastroenterology;2019-09-04

5. Impact of serum albumin levels on the body fluid response to tolvaptan in chronic kidney disease patients;International Urology and Nephrology;2019-06-03